{"id":"W2805042130","doi":"10.1007/s11926-018-0746-0","title":"Novel Therapeutics in Psoriatic Arthritis. What Is in the Pipeline?","year":2018,"lang":"en","type":"review","venue":"Current Rheumatology Reports","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Psoriatic arthritis; Infliximab; Janus kinase; Tofacitinib; Adalimumab; Secukinumab; Etanercept; Clinical trial; Apremilast; Psoriasis; Oncology; Internal medicine; Rheumatoid arthritis; Tumor necrosis factor alpha; Immunology; Cytokine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001576153,0.000756581,0.002255601,0.002099463,0.0003874876,0.001922423,0.001132829,0.001767555,0.006609066],"category_scores_gemma":[0.002156985,0.0003930831,0.001227594,0.002034363,0.0006644838,0.002561375,0.0007992446,0.003159339,0.001930962],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006558373,"about_ca_system_score_gemma":0.001995961,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001304299,"about_ca_topic_score_gemma":0.003613793,"domain_scores_codex":[0.9994807,0.0001357201,0.0001069359,0.00006612938,0.0001592004,0.00005131174],"domain_scores_gemma":[0.9984152,0.0009382032,0.0002077465,0.00003897036,0.0003062063,0.0000936044],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002104279,0.0001081224,0.0001551897,0.04079945,0.0002114827,0.0001640802,0.00007841018,0.0001870116,0.0007666756,0.003363603,0.04166547,0.9122899],"study_design_scores_gemma":[0.00009715714,0.0002131579,0.0008212823,0.02809533,0.000551715,0.001296195,0.000179143,0.000139129,0.000308783,0.003514094,0.964753,0.00003107672],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000026627,0.9991087,0.00002317806,0.0005064605,0.000155334,0.000001677307,0.000007710744,0.000002073417,0.0001681114],"genre_scores_gemma":[0.0003027343,0.9989121,0.00006196372,0.000343614,0.0002287101,0.000003569604,0.000009442452,5.726533e-7,0.0001373674],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006609066,"threshold_uncertainty_score":0.02210951,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08134780759284695,"score_gpt":0.3810852391974094,"score_spread":0.2997374316045625,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}